Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Share your knowledge and expertise with your regulatory peers by submitting an in-depth, evidence-based article focusing on key areas and emerging issues in the global regulatory landscape.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
RAPS Euro Convergence brings regulatory peers from the EU and worldwide together in one forum to gain insights and exchange ideas on the region's most pressing issues. Register today to attend 10-12 May 2021.
Registration is now open for RAPS Convergence 2021! Gather with the regulatory community 12-15 September for four days of learning, engagement, and excitement.
With contributions from more than 30 authors from seven countries, the new edition incorporates a global overview of the field and is designed to help you get the most out of your regulatory intelligence endeavors.
Regipedia is an interactive resource created to benefit RAPS members with 24/7 access to more than 2,300 regulatory terms.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 12 February 2015 | By Alexander Gaffney, RAC,
Even small devices can cause big problems. That's the conclusion of a new guidance document issued this week by the US Food and Drug Administration (FDA), which is trying to make "small-bore connectors" safer.
The devices—technically a medical device—are used to temporarily connect two otherwise incompatible medical devices, FDA explains in its final guidance document, Safety Considerations to Mitigate the Risks of Misconnections with Smallbore Connectors Intended for Enteral Applications.
For example, a small-bore connector might connect an IV tube implanted in a patient's arm to a bag of saline solution, or a feeding tube implanted in a patient's stomach to enteral nutrition.
The problem, FDA explains in the guidance, is that the "use of common connector designs, such as Luer connectors, has led to unintended connections between devices that have different intended uses." This, FDA added, has had fatal consequences for some patients.
Device connectors have been on FDA's radar for other, related reasons in recent years. For example, in April 2013 the agency released a guidance establishing a new standard intended to ensure that pre-filled glass syringes would be able to connect to receiving devices like Luer locks. Regulators recounted that incompatibility between the products had in some cases delayed treatment of patients in life-threatening situations.
FDA's latest guidance, though, confronts the opposite of that problem—devices are too easy to connect together, which has resulted in some patients receiving the incorrect treatment to an improper area.
Now regulators have put the device industry on notice, saying that they’re toughening standards meant to prevent a mismatched connection. "Color-coding, labeling and tagging attached to the device, by themselves, are no longer sufficient to satisfy safety concerns regarding misconnection hazards associated with connectors," FDA explains in the guidance.
Instead, all devices—including small-bore connectors already on the market—will need to comply with new standards developed by the Association for the Advancement of Medical Instrumentation (AAMI) and adopted this week by FDA.
The standards, AAMI/CN3:2014 (PS) Part 3 and AAMI/CN20(PS):2014, aren't available online, but a synopsis of the standards on AAMI's website indicates that the standards call for different physical designs for each connector, and the abandonment of a "universal design."
FDA said devices requiring modification to meet the new standard will be able to submit a declaration of conformity to the standard to modify their existing 510(k) application. This policy will allow companies to update their devices without needing to file a new 510(k), FDA said.
Safety Considerations to Mitigate the Risks of Misconnections with Smallbore Connectors Intended for Enteral Applications (FR)
Tags: Small-Bore Connectors, Enteral Connectors, Luer Locks, AAMI, Guidance, Final Guidance
Regulatory Focus newsletters
All the biggest regulatory news and happenings.